Chad Morreale, DO (@cvomed) 's Twitter Profile Photo

How to approach pts with PAD 1. Clinical presentation 2. Physiologic testing - Rest +/- exercise ABI - Segmental pressures and PVR 3. Anatomical characterization - Aortoiliac: TASC II - Fempop: GLASS - Infrapop: GLASS 4. Tissue loss - WIFI score #NYEVS23 NY Endovascular Summit

How to approach pts with PAD

1. Clinical presentation
2. Physiologic testing
- Rest +/- exercise ABI
- Segmental pressures and PVR
3. Anatomical characterization
- Aortoiliac: TASC II
- Fempop: GLASS 
- Infrapop: GLASS
4. Tissue loss
- WIFI score

#NYEVS23 <a href="/EndovascularNy/">NY Endovascular Summit</a>
Chad Morreale, DO (@cvomed) 's Twitter Profile Photo

How are we doing with medical mgmt of PAD? Poorly. Only 29% of pts have LDLc < 70 and 40% of pts are on no lipid lowering therapy. Antiplatelet, xarelto 2.5 mg BID (COMPASS, VOYAGER PAD), smoking cessation, risk factor mod, exercise program also crucial! #NYEVS23 NY Endovascular Summit

How are we doing with medical mgmt of PAD? Poorly. Only 29% of pts have LDLc &lt; 70 and 40% of pts are on no lipid lowering therapy. Antiplatelet, xarelto 2.5 mg BID (COMPASS, VOYAGER PAD), smoking cessation, risk factor mod, exercise program also crucial! #NYEVS23 <a href="/EndovascularNy/">NY Endovascular Summit</a>
Chad Morreale, DO (@cvomed) 's Twitter Profile Photo

Sahil A. Parikh, MD drumming up excitement at NY Endovascular Summit for LIFE-BTK trial results that will be presented in 1 mo at TCT Conference. Important trial for BTK intervention - deliver drug and resist recoil without leaving scaffold behind #NYEVS23 #CLTIFighters

<a href="/sahilparikhmd/">Sahil A. Parikh, MD</a> drumming up excitement at <a href="/EndovascularNy/">NY Endovascular Summit</a> for LIFE-BTK trial results that will be presented in 1 mo at <a href="/TCTConference/">TCT Conference</a>. Important trial for BTK intervention - deliver drug and resist recoil without leaving scaffold behind #NYEVS23 #CLTIFighters